134 related articles for article (PubMed ID: 6374413)
1. Relationship between plasma arginine vasopressin and renal water handling in decompensated cirrhosis.
Epstein M; Weitzman RE; Preston S; DeNunzio AG
Miner Electrolyte Metab; 1984; 10(3):155-65. PubMed ID: 6374413
[TBL] [Abstract][Full Text] [Related]
2. Effects of water immersion on plasma catecholamines in decompensated cirrhosis. Implications for deranged sodium and water homeostasis.
Epstein M; Larios O; Johnson G
Miner Electrolyte Metab; 1985; 11(1):25-34. PubMed ID: 3883119
[TBL] [Abstract][Full Text] [Related]
3. Isoosmotic central blood volume expansion suppresses plasma arginine vasopressin in normal man.
Epstein M; Preston S; Weitzman RE
J Clin Endocrinol Metab; 1981 Feb; 52(2):256-62. PubMed ID: 7007402
[TBL] [Abstract][Full Text] [Related]
4. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
5. Determinants of deranged sodium and water homeostasis in decompensated cirrhosis.
Epstein M; Pins DS; Schneider N; Levinson R
J Lab Clin Med; 1976 May; 87(5):822-39. PubMed ID: 1270890
[TBL] [Abstract][Full Text] [Related]
6. Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.
Tulassay T; Tulassay Z; Büki B; Szathmári M; Rascher W
Acta Med Hung; 1988; 45(1):73-81. PubMed ID: 2970621
[TBL] [Abstract][Full Text] [Related]
7. Partial renal resistance to arginine vasopressin as an adaptation to high altitude living.
Ramirez G; Pineda D; Bittle PA; Rabb H; Rosen R; Vesely D; Sasaki S
Aviat Space Environ Med; 1998 Jan; 69(1):58-65. PubMed ID: 9451536
[TBL] [Abstract][Full Text] [Related]
8. Failure of water immersion to influence parathyroid hormone secretion and renal phosphate handling in normal man.
Epstein M; Pins DS; Silvers W; Loutzenhiser R; Canterbury JM; Reiss E
J Lab Clin Med; 1976 Feb; 87(2):218-26. PubMed ID: 1245788
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T
Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829
[TBL] [Abstract][Full Text] [Related]
10. Hormonal regulation of water metabolism in children with nephrotic syndrome.
Rascher W; Tulassay T
Kidney Int Suppl; 1987 Aug; 21():S83-9. PubMed ID: 3306110
[TBL] [Abstract][Full Text] [Related]
11. Hyponatremia and arginine vasopressin secretion in patients with refractory hepatic ascites undergoing peritoneovenous shunting.
Reznick RK; Langer B; Taylor BR; Seif S; Blendis LM
Gastroenterology; 1983 Apr; 84(4):713-8. PubMed ID: 6337910
[TBL] [Abstract][Full Text] [Related]
12. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
Jespersen B
Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
[TBL] [Abstract][Full Text] [Related]
13. Suppression of ADH during water immersion in normal man.
Epstein M; Pins DS; Miller M
J Appl Physiol; 1975 Jun; 38(6):1038-44. PubMed ID: 1141116
[TBL] [Abstract][Full Text] [Related]
14. Water excretion in the elderly.
Davis PJ; Davis FB
Endocrinol Metab Clin North Am; 1987 Dec; 16(4):867-75. PubMed ID: 3322820
[TBL] [Abstract][Full Text] [Related]
15. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.
Bichet DG; Van Putten VJ; Schrier RW
N Engl J Med; 1982 Dec; 307(25):1552-7. PubMed ID: 6755251
[TBL] [Abstract][Full Text] [Related]
16. Oral V2 receptor antagonist (RWJ-351647) in patients with cirrhosis and ascites: a randomized, double-blind, placebo-controlled, single ascending dose study.
Thuluvath PJ; Maheshwari A; Wong F; Yoo HW; Schrier RW; Parikh C; Steare S; Korula J
Aliment Pharmacol Ther; 2006 Sep; 24(6):973-82. PubMed ID: 16948809
[TBL] [Abstract][Full Text] [Related]
17. Dietary sodium intake and vasopressin excretion in man.
Kjeldsen SE; Forsberg G; Eide I; Aakesson I; Os I; Skjøtø J; Frederichsen P
J Hypertens Suppl; 1984 Dec; 2(3):S301-3. PubMed ID: 6599675
[TBL] [Abstract][Full Text] [Related]
18. Evidence for operation of the magnification phenomenon in patients with chronic renal insufficiency.
Epstein M; Hoffman D; DeNunzio AG
Miner Electrolyte Metab; 1983; 9(2):62-8. PubMed ID: 6843521
[TBL] [Abstract][Full Text] [Related]
19. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
[TBL] [Abstract][Full Text] [Related]
20. Arginine vasopressin, circulation, and kidney during graded water immersion in humans.
Norsk P; Bonde-Petersen F; Warberg J
J Appl Physiol (1985); 1986 Aug; 61(2):565-74. PubMed ID: 3745047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
